Word

Status

Registered

Status Code

700

Status Date

Tuesday, October 13, 2020

Serial Number

88664634

Registration Number

6172948

Registration Date

Tuesday, October 13, 2020

Mark Type

2

Filing Date

Tuesday, October 22, 2019

Published for Opposition

Tuesday, July 28, 2020

Trademark Owner History

INCYTE HOLDINGS CORPORATION -
MorphoSys AG - Original Registrant

Classifications

5 Pharmaceuticals and pharmaceutical preparations for human and veterinary use for the treatment and prevention of metabolic disorders, infectious diseases, cancer, inflammatory diseases, Alzheimer, sepsis, and restenosis; vaccine preparations; vaccines; biological preparations in the nature of antibodies for use in the treatment of metabolic disorders, infectious diseases, cancer, inflammatory diseases, Alzheimer, sepsis, and restenosis; antibodies sold as a component ingredient of pharmaceuticals for the treatment of metabolic disorders, infectious diseases, cancer, inflammatory diseases, Alzheimer, sepsis, and restenosis; antibodies for use in the manufacture of active ingredients of pharmaceuticals and vaccines; diagnostic preparations for medical or veterinary purposes; biological preparations for human medical diagnostics and analysis for the treatment of metabolic disorders, infectious diseases, cancer, inflammatory diseases, Alzheimer, sepsis, and restenosis; sanitary preparations for medical use; medical diagnostic reagents; clinical medical reagents; biological preparations for medical and veterinary purposes for the treatment of metabolic disorders, infectious diseases, cancer, inflammatory diseases, Alzheimer, sepsis, and restenosis

42 Research and development in the pharmaceutical and biotechnology fields; research and development of vaccines and medicines; scientific and technological services and research and design services, namely, scientific research, analysis, and testing services in the fields of analytical chemistry, biochemistry, medicinal chemistry, drug development, biotechnology, microbiology and molecular biology; biological research and medical research; chemical and biochemical analysis services; laboratory research in the fields of analytical chemistry, biochemistry, medicinal chemistry, drug development, biotechnology, microbiology and molecular biology; clinical research in connection with the treatment and prevention of metabolic disorders, infectious diseases, cancer, inflammatory diseases, Alzheimer, sepsis, and restenosis; conducting clinical trials for others; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Research and development services in the field of antibodies

The mark consists of of three arrow points.
Color is not claimed as a feature of the mark.

Trademark Events

Oct 25, 2019

New Application Entered

Oct 29, 2019

New Application Office Supplied Data Entered

Oct 30, 2019

Notice Of Design Search Code E-Mailed

Nov 17, 2019

Teas Voluntary Amendment Received

Nov 21, 2019

Assigned To Lie

Nov 22, 2019

Preliminary/Voluntary Amendment - Entered

Dec 15, 2019

Assigned To Examiner

Dec 18, 2019

Suspension Letter Written

Dec 18, 2019

Letter Of Suspension E-Mailed

Dec 18, 2019

Notification Of Letter Of Suspension E-Mailed

Jun 12, 2020

Teas/Email Correspondence Entered

Jun 10, 2020

Teas Response To Suspension Inquiry Received

Jun 12, 2020

Correspondence Received In Law Office

Jun 15, 2020

Approved For Pub - Principal Register

Jun 19, 2020

On Hold - Electronic Record Review Required

Jun 24, 2020

Electronic Record Review Complete

Jul 28, 2020

Published For Opposition

Jul 28, 2020

Official Gazette Publication Confirmation E-Mailed

Jul 8, 2020

Notification Of Notice Of Publication E-Mailed

Oct 13, 2020

Registered-Principal Register

May 1, 2024

Automatic Update Of Assignment Of Ownership

Apr 24, 2024

Assignment Of Ownership Not Updated Automatically